These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3115267)

  • 1. Development of potent aldose reductase inhibitors having a hydantoin structure.
    Miwa I; Hirano M; Inagaki K; Belbeoc'h C; Okuda J
    Biochem Pharmacol; 1987 Sep; 36(17):2789-94. PubMed ID: 3115267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiro hydantoin aldose reductase inhibitors.
    Sarges R; Schnur RC; Belletire JL; Peterson MJ
    J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
    Griffin BW; McNatt LG; Chandler ML; York BM
    Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure.
    Miwa I; Hirano M; Kanbara M; Okuda J
    Biochem Pharmacol; 1990 Jul; 40(2):303-7. PubMed ID: 2115779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanones.
    Sarges R; Goldstein SW; Welch WM; Swindell AC; Siegel TW; Beyer TA
    J Med Chem; 1990 Jul; 33(7):1859-65. PubMed ID: 2113948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Lim SS; Jung SH; Ji J; Shin KH; Keum SR
    J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D; Mirrlees DJ; Harrison HE; Earl DC
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats.
    Kato K; Nakayama K; Ohta M; Murakami N; Murakami K; Mizota M; Miwa I; Okuda J
    Eur J Pharmacol; 1991 Feb; 193(2):185-91. PubMed ID: 1828768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R; Mirrlees DJ; Earl DC; Heath H
    Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.
    Simard-Duquesne N; Greselin E; Dubuc J; Dvornik D
    Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
    Inagaki K; Miwa I; Yashiro T; Okuda J
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3244-54. PubMed ID: 6816474
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA; Chakrabarti S; Lattimer SA; Sima AA
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH; Tomlinson DR; McLean WG
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of nerve conduction velocity in mutant diabetic mice by aldose reductase inhibitor without affecting nerve myo-inositol content.
    Miwa I; Kanbara M; Okuda J
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1581-2. PubMed ID: 2505939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.